George Cardoza

CIK: 0001518734

Transaction Breakdown

Open Market Buys (P)1 (10.0%)

High conviction signal

Open Market Sales (S)8 (80.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (10.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SOPH

SOPHiA GENETICS SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SOPH
SOPHiA GENETICS SA
Oct 5, 2026
Sale(S)
Direct
1.6K shares at avg. $8.10$13K
SOPH
SOPHiA GENETICS SA
Sep 21, 2026
Sale(S)
Direct
774 shares at avg. $8.33$6K
SOPH
SOPHiA GENETICS SA
Jul 6, 2026
Sale(S)
Direct
1.6K shares at avg. $5.29$8K
SOPH
SOPHiA GENETICS SA
Jun 22, 2026
Sale(S)
Direct
774 shares at avg. $5.38$4K
SOPH
SOPHiA GENETICS SA
Jun 5, 2026
Purchase(P)
Direct
20K shares at avg. $4.95$99K
SOPH
SOPHiA GENETICS SA
Apr 8, 2026
Sale(S)
Direct
1.4K shares at avg. $4.85$7K
SOPH
SOPHiA GENETICS SA
Apr 7, 2026
Sale(S)
Direct
2.4K shares at avg. $4.88$12K
SOPH
SOPHiA GENETICS SA
Apr 6, 2026
Sale(S)
Direct
2.5K shares at avg. $4.85$12K
SOPH
SOPHiA GENETICS SA
Apr 2, 2026
Award(A)
Direct
112.9K shares-
SOPH
SOPHiA GENETICS SA
Mar 19, 2026
Sale(S)
Direct
774 shares at avg. $4.79$4K

		Type	Shares	Price		Ownership
Oct 5, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,592	$8.10	$12,897	Direct
Sep 21, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	774	$8.33	$6,447	Direct
Jul 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,592	$5.29	$8,419	Direct
Jun 22, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	774	$5.38	$4,164	Direct
Jun 5, 2026	SOPH SOPHiA GENETICS SA	Purchase(P)	20,000	$4.95	$99,000	Direct
Apr 8, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,403	$4.85	$6,801	Direct
Apr 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,413	$4.88	$11,768	Direct
Apr 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,520	$4.85	$12,211	Direct
Apr 2, 2026	SOPH SOPHiA GENETICS SA	Award(A)	112,936	-	$0	Direct
Mar 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	774	$4.79	$3,705	Direct

1-10 of 10 transactions

About CARDOZA GEORGE

CARDOZA GEORGE (SEC CIK 0001518734) files insider reports with the SEC as Chief Financial Officer of SOPHiA GENETICS SA (SOPH).

Signal8 holds 11 ownership filings by CARDOZA GEORGE (1 Form 3, 10 Form 4), filed between Mar 18, 2026 and Oct 7, 2026. Those filings report 10 transactions, from Mar 19, 2026 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CARDOZA GEORGE's filings is in BOSTON, MA.

Recent filings by CARDOZA GEORGE

Oct 5, 2026: Open-market sale of SOPH shares (Form 4, code S).
Sep 21, 2026: Open-market sale of SOPH shares (Form 4, code S).
Jul 6, 2026: Open-market sale of SOPH shares (Form 4, code S).
Jun 22, 2026: Open-market sale of SOPH shares (Form 4, code S).
Jun 5, 2026: Open-market purchase of SOPH shares (Form 4, code P).

Other insiders filing for SOPHiA GENETICS SA (SOPH)

Menu Philippe, Chief Medical Officer
Xu Zhenyu, Chief Scientific Officer
Camblong Jurgi, Executive Chairman
Van Well Daan, Chief Legal Officer
Valente Manuela, Chief People Officer
Verma Abhimanyu, Chief Technology Officer

How to read Form 4 transaction codes